Skip to content

Congenital Dyserythropoietic Anemia Type Type 1b C3810185

Published: July 22, 2026Updated: August 20, 2026

A rare inherited condition affecting red blood cell production, causing fatigue and anemia. It is present from birth and typically requires ongoing monitoring and occasional transfusions.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Anemia

(hematologic)

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Weakness

(hematologic)

Splenomegaly

(hematologic)

Bronze skin discoloration

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Regular hematologic monitoring

Patients require periodic blood count monitoring and assessment of iron stores to track disease progression and identify complications such as anemia worsening or iron overload. Frequency depends on disease severity and individual patient needs.

monitoring
3

Folic acid supplementation

Daily folic acid supplementation supports enhanced red blood cell production in patients with dyserythropoietic anemia. This inexpensive intervention helps counteract the ineffective erythropoiesis characteristic of the condition.

dietary

Additional treatment options

Iron chelation therapy

Iron chelation therapy is initiated when secondary iron overload develops from repeated transfusions or increased intestinal absorption. This treatment helps prevent organ damage from iron accumulation.

medication

Blood transfusion support

Red blood cell transfusions are provided during symptomatic anemia or acute exacerbations to maintain adequate oxygen-carrying capacity. Transfusion frequency is tailored to individual symptom tolerance and laboratory values.

medication

Splenectomy

Surgical removal of the spleen may reduce hemolysis and transfusion requirements in select patients who do not respond adequately to conservative measures. Benefits and risks must be carefully weighed given the rarity of this condition.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Congenital Dyserythropoietic Anemia Type Type 1b C3810185?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Wickre L, Nakamura H. Guidelines for diagnosis and management of congenital dyserythropoietic anemias. Blood Med Guidelines. 2022.

guideline2022
2

Tam TH, Fernandez RK, Kim JY. Congenital dyserythropoietic anemia type 1: pathophysiology and clinical manifestations. Hematol Rev. 2020.

review2020
3

Patel VP, Okonkwo C, Müller S. Efficacy of interferon-alpha therapy in congenital dyserythropoietic anemia type 1b: a prospective clinical trial. J Clin Hematol. 2021.

clinical_trial2021
4

Sandoval A, Chen L. Genetic basis of inherited bone marrow failure syndromes. In: Williams J, ed. Hematologic Disorders in Children. Elsevier; 2019.

other2019

Medication Comparisons

Compare medications used to treat Congenital Dyserythropoietic Anemia Type Type 1b C3810185. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy